Multi-Stakeholder Qualitative Interviews to Inform Measurement of Patient Reported Outcomes After CAR-T

Toxicities after chimeric antigen receptor T cell (CAR-T) therapy are well known, yet the patient experience during and after CAR-T therapy has not been well described outside of the trial setting. We explored the patient experience after CAR-T therapy to inform the patient-reported outcomes (PRO) m...

Descripción completa

Detalles Bibliográficos
Autores principales: Akinola, Idayat M., Cusatis, Rachel, Pasquini, Marcelo C., Shaw, Bronwen E., Bollu, Vamsi, Dalal, Anand, Tesfaye, Mimi, Flynn, Kathryn E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369368/
https://www.ncbi.nlm.nih.gov/pubmed/36634738
http://dx.doi.org/10.1016/j.jtct.2023.01.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369368/
https://www.ncbi.nlm.nih.gov/pubmed/36634738
http://dx.doi.org/10.1016/j.jtct.2023.01.004

Ejemplares similares